Retention on buprenorphine treatment reduces emergency department utilization, but not hospitalization, among treatment-seeking patients with opioid dependence

Journal of Substance Abuse Treatment

Volumn 43, Issue 4, 2012, Pages 451-457

  Schwarz, Ryan ^a,b,c   Zelenev, Alexei ^c   Bruce, R Douglas ^c,d   Altice, Frederick L ^c,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d YALE UNIVERSITY   (United States)

Author keywords

Buprenorphine; Emergency department utilization; Healthcare utilization; Hospitalization; Longitudinal cohort; Methadone; Opioid dependence; Substance abuse

Indexed keywords

BUPRENORPHINE;

ADULT; ARTICLE; BINOMIAL DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG USE; EMERGENCY WARD; FEMALE; HEALTH CARE UTILIZATION; HELP SEEKING BEHAVIOR; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; PRIORITY JOURNAL;

ADULT; BUPRENORPHINE; COHORT STUDIES; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; TIME FACTORS; YOUNG ADULT;

EID: 84868150280     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2012.03.008     Document Type: Article

References (43)

1. The impact of screening, brief intervention and referral for treatment in emergency department patients' alcohol use: A 3-, 6- and 12-month follow-up. Alcohol and Alcoholism 2010, 45:514-519. Academic ED SBIRT Research Collaborative.
2. Agency for Healthcare Research and Quality Medical Expenditure Panel Survey Accessed at, on May 25, 2011. accessed on. http://www.meps.ahrq.gov/mepsweb/.
3. Alford D.P., LaBelle C.T., Kretsch N., Bergeron A., Winter M., Botticelli M., et al. Collaborative care of opioid-addicted patients in primary care using buprenorphine: Five-year experience. Archives of Internal Medicine 2011, 171:425-431.
4. Altice F.L., Bruce R.D., Lucas G.M., Lum P.J., Korthuis P.T., Flanigan T.P., et al. HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: Results from a multisite study. Journal of Acquired Immune Deficiency Syndromes 2011, 56(Suppl. 1):S22-S32.
5. Altice F.L., Kamarulzaman A., Soriano V.V., Schechter M., Friedland G.H. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet 2010, 376:59-79.
6. Altice F.L., Springer S., Buitrago M., Hunt D.P., Friedland G.H. Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users. Journal of Urban Health 2003, 80:416-427.
7. Altice F.L., Sullivan L.E., Smith-Rohrberg D., Basu S., Stancliff S., Eldred L. The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention. Clinical Infectious Diseases 2006, 43(Suppl. 4):S178-S183.
8. Barnett P.G., Hui S.S. The cost-effectiveness of methadone maintenance. Mount Sinai Journal of Medicine 2000, 67:365-374.
9. Barnett P.G., Zaric G.S., Brandeau M.L. The cost-effectiveness of buprenorphine maintenance therapy for opiate addiction in the United States. Addiction 2001, 96:1267-1278.
10. Basu S., Smith-Rohrberg D., Bruce R.D., Altice F.L. Models for integrating buprenorphine therapy into the primary HIV care setting. Clinical Infectious Diseases 2006, 42:716-721.
11. Bruce R.D. Methadone as HIV prevention: High volume methadone sites to decrease HIV incidence rates in resource limited settings. International Journal on Drug Policy 2010, 21:122-124.
12. Bruce R.D., Altice F.L. Case series on the safe use of buprenorphine/naloxone in individuals with acute hepatitis C infection and abnormal hepatic liver transaminases. American Journal of Drug and Alcohol Abuse 2007, 33:869-874.
13. Carrieri M.P., Amass L., Lucas G.M., Vlahov D., Wodak A., Woody G.E. Buprenorphine use: The international experience. Clinical Infectious Diseases 2006, 43:S197-S215.
14. Center for Substance Abuse Treatment Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40 2004, Department of Health and Human Services, Rockville, MD. Substance Abuse and Mental Health Services Administration (SAMHSA) (Ed.).
15. Chuang E., Wells R., Alexander J.A. Public managed care and service access in outpatient substance abuse treatment units. Journal of Behavioral Health Services and Research 2011, 38:444-463.
16. Copenhaver M.M., Bruce R.D., Altice F.L. Behavioral counseling content for optimizing the use of buprenorphine for treatment of opioid dependence in community-based settings: A review of the empirical evidence. American Journal of Drug and Alcohol Abuse 2007, 33:643-654.
17. Ettner S.L., Huang D., Evans E., Ash D.R., Hardy M., Jourabchi M., et al. Benefit-Cost in the California treatment outcome project: Does substance abuse treatment "pay for itself"?. Health Services Research 2006, 41:192-213.
18. French M.T., McGeary K.A., Chitwood D.D., McCoy C.B. Chronic illicit drug use, health services utilization and the cost of medical care. Social Science & Medicine 2000, 50:1703-1713.
19. Friedmann P.D., Hendrickson J.C., Gerstein D.R., Zhang Z., Stein M.D. Do mechanisms that link addiction treatment patients to primary care influence subsequent utilization of emergency and hospital care?. Medical Care 2006, 44:8-15.
20. Kakko J., Svanborg K.D., Kreek M.J., Heilig M. 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: A randomised, placebo-controlled trial. Lancet 2003, 361:662-668.
21. Kerr T., Wood E., Grafstein E., Ishida T., Shannon K., Lai C., et al. High rates of primary care and emergency department use among injection drug users in Vancouver. Journal of Public Health (Oxford, England) 2005, 27:62-66.
22. Knowlton A.R., Hoover D.R., Chung S.E., Celentano D.D., Vlahov D., Latkin C.A. Access to medical care and service utilization among injection drug users with HIV/AIDS. Drug and Alcohol Dependence 2001, 64:55-62.
23. Laine C., Hauck W.W., Gourevitch M.N., Rothman J., Cohen A., Turner B.J. Regular outpatient medical and drug abuse care and subsequent hospitalization of persons who use illicit drugs. Journal of the American Medical Association 2001, 285:2355-2362.
24. Laine C., Lin Y.T., Hauck W.W., Turner B.J. Availability of medical care services in drug treatment clinics associated with lower repeated emergency department use. Medical Care 2005, 43:985-995.
25. Leonardi C., Hanna N., Laurenzi P., Fagetti R. Multi-centre observational study of buprenorphine use in 32 Italian drug addiction centres. Drug and Alcohol Dependence 2008, 94:125-132. Group, I.D.A.C.
26. Magnus M., Schmidt N., Kirkhart K., Schieffelin C., Fuchs N., Brown B., et al. Association between ancillary services and clinical and behavioral outcomes among HIV-infected women. AIDS Patient Care and STDs 2001, 15:137-145.
27. Marsch L.A., Stephens M.A., Mudric T., Strain E.C., Bigelow G.E., Johnson R.E. Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence. Experimental and Clinical Psychopharmacology 2005, 13:293-302.
28. Masson C.L., Sorensen J.L., Batki S.L., Okin R., Delucchi K.L., Perlman D.C. Medical service use and financial charges among opioid users at a public hospital. Drug and Alcohol Dependence 2002, 66:45-50.
29. McGeary K.A., French M.T. Illicit drug use and emergency room utilization. Health Services Research 2000, 35:153-169.
30. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., et al. The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment 1992, 9:199-213.
31. Mizuno Y., Wilkinson J.D., Santibanez S., Dawson Rose C., Knowlton A., Handley K., et al. Correlates of health care utilization among HIV-seropositive injection drug users. AIDS Care 2006, 18:417-425.
32. Mowbray O., Perron B.E., Bohnert A.S., Krentzman A.R., Vaughn M.G. Service use and barriers to care among heroin users: Results from a national survey. American Journal of Drug and Alcohol Abuse 2010, 36:305-310.
33. Palepu A., Strathdee S.A., Hogg R.S., Anis A.H., Rae S., Cornelisse P.G., et al. The social determinants of emergency department and hospital use by injection drug users in Canada. Journal of Urban Health 1999, 76:409-418.
34. Palepu A., Tyndall M.W., Leon H., Muller J., O'Shaughnessy M.V., Schechter M.T., et al. Hospital utilization and costs in a cohort of injection drug users. CMAJ 2001, 165:415-420.
35. Pollack H.A., Khoshnood K., Blankenship K.M., Altice F.L. The impact of needle exchange-based health services on emergency department use. Journal of General Internal Medicine 2002, 17:341-348.
36. Roy K., Miller M. Parity and the medicalization of addiction treatment. Journal of Psychoactive Drugs 2010, 42:115-120.
37. Schwarz R.K., Bruce R.D., Ball S.A., Herme M., Altice F.L. Comparison of tuberculin skin testing reactivity in opioid-dependent patients seeking treatment with methadone versus buprenorphine: Policy implications for tuberculosis screening. American Journal of Drug and Alcohol Abuse 2009, 35:439-444.
38. Stein M.D., Anderson B. Injection frequency mediates health service use among persons with a history of drug injection. Drug and Alcohol Dependence 2003, 70:159-168.
39. Stein M.D., Cioe P., Friedmann P.D. Buprenorphine retention in primary care. Journal of General Internal Medicine 2005, 20:1038-1041.
40. Stein M.D., O'Sullivan P.S., Ellis P., Perrin H., Wartenberg A. Utilization of medical services by drug abusers in detoxification. Journal of Substance Abuse 1993, 5:187-193.
41. Stenbacka M., Leifman A., Romelsjo A. The impact of methadone on consumption of inpatient care and mortality, with special reference to HIV status. Substance Use & Misuse 1998, 33:2819-2834.
42. Sullivan L.E., Moore B.A., O'Connor P.G., Barry D.T., Chawarski M.C., Schottenfeld R.S., et al. The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence. American Journal on Addictions 2006, 19:53-58.
43. Thompson A.S., Blankenship K.M., Selwyn P.A., Khoshnood K., Lopez M., Balacos K., et al. Evaluation of an innovative program to address the health and social service needs of drug-using women with or at risk for HIV infection. Journal of Community Health 1998, 23:419-440.